WEB CONFERENCE

Theraclion completes first varicose veins study on June 18, 3pm CET

Varicose veins treatment by Echopulse

Presentation made by Dr Alfred Obermayer at International Veins Congress.

Watch the video

THERACLION

Specialising in
the non-invasive
treatment of tumours

ECHOTHERAPY

An innovative solution using focused, guided ultrasound

ECHOPULSE®

A disruptive innovation

Investors area

Click here for financial information

About us

Theraclion is a French company specialising in high-tech therapeutic ultrasound equipment. We design and market Echopulse®, an innovative echotherapy solution.

Our product: Echopulse®

The Echopulse® device combines focused ultrasound therapy with ultrasound imaging for accurate, tailored and non-invasive treatment of tumours.

Pathologies treated

Echopulse®, Theraclion's echotherapy solution, has obtained CE marking for two pathologies: breast fibroadenomas and thyroid nodules.

Echotherapy is a unique combination of high-intensity focused ultrasound (HIFU) therapy and real-time ultrasound monitoring.
It's a viable alternative to surgery and to monitoring, enabling the non-invasive treatment of benign tumours (breast fibroadenomas and thyroid nodules) without scarring.

Testimonial

Dr Marc Abehsera

Radiologist at the American Hospital of Paris - France

« In the HIFU treatment of breast fibroadenoma, first results are encouraging for an outpatient technique very well tolerated with significant fibroadenoma’s volume reductions.»

Plenary session presentation - JFR 2012

READ THE OTHER TESTIMONIALS

Stay informed about the opening of future Echotherapy centers nearest to you, by clicking here

Web conference on June 18, 3pm CET

Theraclion completes first varicose veins study
Press Release – 07.06.2018

Theraclion announces a major milestone in its efforts to enter into the varicose veins market:
Press Release – 05.06.2018

Theraclion announces today significant milestones in sales and business development in the German market.

Echopulse® is a medical device designed and marketed by Theraclion for use by health professionals in treating patients with breast fibroadenomas and benign thyroid nodules. It is a regulated health product and, in accordance with the above Act, it bears the CE marking. Consult your health professional before any procedure.